Next Article in Journal
Molluscicidal Activity of Methomyl and Cardenolide Extracts from Calotropis procera and Adenium arabicum Against the Land Snail Monacha cantiana
Previous Article in Journal
Kale Extract Increases Glutathione Levels in V79 Cells, but Does not Protect Them against Acute Toxicity Induced by Hydrogen Peroxide
Previous Article in Special Issue
Bio-Functional Constituents from the Stems of Liriodendron tulipifera
Article Menu

Export Article

Open AccessReview
Molecules 2012, 17(5), 5289-5309;

The Pharmacological Properties and Therapeutic Use of Apomorphine

Institute of Pathophysiology, Medical Faculty, University of Ljubljana, Zaloška 4, SI-1000 Ljubljana, Slovenia
Laboratory for Movement Disorders, Department of Neurological Disorders, University Clinical Centre Ljubljana, Zaloška 2, SI-1000 Ljubljana, Slovenia
Received: 1 March 2012 / Revised: 22 April 2012 / Accepted: 25 April 2012 / Published: 7 May 2012
PDF [581 KB, uploaded 18 June 2014]


Apomorphine (APO) is an aporphine derivative used in human and veterinary medicine. APO activates D1, D2S, D2L, D3, D4, and D5 receptors (and is thus classified as a non-selective dopamine agonist), serotonin receptors (5HT1A, 5HT2A, 5HT2B, and 5HT2C), and α-adrenergic receptors (α1B, α1D, α2A, α2B, and α2C). In veterinary medicine, APO is used to induce vomiting in dogs, an important early treatment for some common orally ingested poisons (e.g., anti-freeze or insecticides). In human medicine, it has been used in a variety of treatments ranging from the treatment of addiction (i.e., to heroin, alcohol or cigarettes), for treatment of erectile dysfunction in males and hypoactive sexual desire disorder in females to the treatment of patients with Parkinson's disease (PD). Currently, APO is used in patients with advanced PD, for the treatment of persistent and disabling motor fluctuations which do not respond to levodopa or other dopamine agonists, either on its own or in combination with deep brain stimulation. Recently, a new and potentially important therapeutic role for APO in the treatment of Alzheimer’s disease has been suggested; APO seems to stimulate Ab catabolism in an animal model and cell culture, thus reducing the rate of Ab oligomerisation and consequent neural cell death. View Full-Text
Keywords: apomorphine; Alzheimer’s disease; dopamine agonist; erectile dysfunction; Parkinson’s disease apomorphine; Alzheimer’s disease; dopamine agonist; erectile dysfunction; Parkinson’s disease

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Ribarič, S. The Pharmacological Properties and Therapeutic Use of Apomorphine. Molecules 2012, 17, 5289-5309.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top